Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8-and-9-mediated apoptotic pathways in dopaminergic neurons

被引:189
作者
Choi, WS
Eom, DS
Han, BS
Kim, WK
Han, BH
Choi, EJ
Oh, TH
Markelonis, GJ
Cho, JW
Oh, YJ
机构
[1] Yonsei Univ, Coll Sci, Dept Biol, Seoul 120749, South Korea
[2] Yonsei Univ, Coll Sci, Prot Network Res Ctr, Seoul 120749, South Korea
[3] Ewha Womans Univ, Sch Med, Dept Pharmacol, Seoul 110783, South Korea
[4] Seoul Natl Univ, Coll Pharm, Inst Nat Prod Res, Seoul 110460, South Korea
[5] Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea
[6] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA
关键词
D O I
10.1074/jbc.M311164200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We evaluated the contribution of p38 mitogen-activated protein kinase and the events upstream/downstream of p38 leading to dopaminergic neuronal death. We utilized MN9D cells and primary cultures of mesencephalic neurons treated with 6-hydroxydopamine. Phosphorylation of p38 preceded apoptosis and was sustained in 6-hydroxydopamine-treated MN9D cells. Co-treatment with PD169316 ( an inhibitor of p38) or expression of a dominant negative p38 was neuroprotective in death induced by 6-hydroxydopamine. The superoxide dismutase mimetic and the nitric oxide chelator blocked 6-hydroxydopamine-induced phosphorylation of p38, suggesting a role for superoxide anion and nitric oxide in eliciting a neurotoxic signal by activating p38. Following 6-hydroxydopamine treatment, inhibition of p38 prevented both caspase-8- and -9-mediated apoptotic pathways as well as generation of truncated Bid. Consequently, 6-hydroxydopamine-induced cell death was rescued by blockading activation of caspase-8 and -9. In primary cultures of mesencephalic neurons, the phosphorylation of p38 similarly appeared in tyrosine hydroxylasepositive, dopaminergic neurons after 6-hydroxydopamine treatment. This neurotoxin-induced phosphorylation of p38 was inhibited in the presence of superoxide dismutase mimetic or nitric oxide chelator. Co-treatment with PD169316 deterred 6-hydroxydopamine-induced loss of dopaminergic neurons and activation of caspase-3 in these neurons. Furthermore, inhibition of caspase-8 and -9 significantly rescued 6-hydroxydopamine-induced loss of dopaminergic neurons. Taken together, our data suggest that superoxide anion and nitric oxide induced by 6-hydroxydopamine initiate the p38 signal pathway leading to activation of both mitochondrial and extramitochondrial apoptotic pathways in our culture models of Parkinson's disease.
引用
收藏
页码:20451 / 20460
页数:10
相关论文
共 56 条
[1]   Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice [J].
Asanuma, M ;
Hirata, H ;
Cadet, JL .
NEUROSCIENCE, 1998, 85 (03) :907-917
[2]   Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine [J].
Barkats, M ;
Millecamps, S ;
Bilang-Bleuel, A ;
Mallet, J .
JOURNAL OF NEUROCHEMISTRY, 2002, 82 (01) :101-109
[3]  
Barone FC, 2001, MED RES REV, V21, P129, DOI 10.1002/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO
[4]  
2-H
[5]  
Bindokas VP, 1996, J NEUROSCI, V16, P1324
[6]   Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-κB in cellular models of Parkinson's disease [J].
Cassarino, DS ;
Halvorsen, EM ;
Swerdlow, RH ;
Abramova, NN ;
Parker, WD ;
Sturgill, TW ;
Bennett, JP .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (04) :1384-1392
[7]   p38 MAP kinase mediates nitric oxide-induced apoptosis of neural progenitor cells [J].
Cheng, AW ;
Chan, SL ;
Milhavet, O ;
Wang, SQ ;
Mattson, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (46) :43320-43327
[8]   IMMORTALIZATION OF EMBRYONIC MESENCEPHALIC DOPAMINERGIC-NEURONS BY SOMATIC-CELL FUSION [J].
CHOI, HK ;
WON, LA ;
KONTUR, PJ ;
HAMMOND, DN ;
FOX, AP ;
WAINER, BH ;
HOFFMANN, PC ;
HELLER, A .
BRAIN RESEARCH, 1991, 552 (01) :67-76
[9]  
Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.3.CO
[10]  
2-5